• Registration, Cancellation policy, Scholarships
  • Auditorium Maximum UJ

Goal

To provide updated diagnostically relevant information on predominantly immunohistochemical markers, useful antibodies, optimal clones and optimal antibody panels applicable in…

Read More

Speakers

(in alphabetical order) Andrew Bellizzi Andrew M Bellizzi, M.D. is a Clinical Professor in the Department of Pathology at the…

Read More

Organizing / Scientific Committee

Course Director: Janusz Ryś MD. PhD. Members: Agnieszka Adamczyk PhDAgnieszka Klimkowska PhD.Jan Klos MD.Artur Kowalik PhD.Anna Kruczak PhD.Krzysztof Okoń MD.…

Read More

Language, Participants

Language: The language of the course is English. Participants: The target groups are consultant pathologists and pathologists in training. The…

Read More

Venue, Travel, Contact

Auditorium Maximum of the Jagiellonian UniversityKrupnicza 33, Kraków(17-19th April 2023) Travel The old city of Krakow is a tourist attraction…

Read More
Read More

Program

PDF file can be downloaded from the top menu.

  • 08.00 – 09.00

    Registration and Coffee

  • 09.00 – 09.10

    Introduction and WelcomeJ. Klos / J. Ryś

  • 09.10 – 10.25

    IHC technology. Critical Preanalytical and Analytical PitfallsS. Nielsen

  • 10.25 – 10.50

    Coffee (25′)

  • 10.50 – 11.40

    IHC – Interpretation Pitfalls J. Klos

  • 11.40 – 12.35

    Radiological – Morphological Correlation in Diagnosing Breast Carcinoma T. Tot

  • 12.35 – 13.30

    Lunch (55′)

  • 13.30 – 14.15

    HER2-low and HER2-negative Breast Cancers Old marker – New challengeT. Tot

  • 14.15 – 15.00

    Metaplastic Breast Carcinoma. The Current State of knowledgeJ. Ryś

  • 15.00 – 15.30

    Coffee (30′)

  • 15.30 – 16.30

    Update on IHC based predictive biomarkers in solid tumors: novel PD-L1 applications and beyondH-U. Schildhaus

  • 16.30 – 18.00

    Consultation Corner – Gynecologic and Soft Tissue PathologyA. Malpica, S. Stolnicu, M. Miettinen

  • 19.30 – 22.00

    Course Dinner

  • 08.30 – 09.25

    Introduction to Molecular Testing of Cancer. Practical Guide to Specimen and Tissue Handling for Molecular diagnostics. Pitfalls and Potentials A. Kowalik

  • 09.25 – 10.20

    FISH in diagnosis and management of solid cancer M. Debiec-Rychter

  • 10.20 – 11.05

    NGS in Routine Diagnostics of solid tumors A. Tysarowski, K. Seliga

  • 11.05 – 11.30

    Coffee (25′)

  • 11.30 – 12.15

    Molecular versus IHC detection of genetic changes in different type of cancer J. Lasota

  • 12.15 – 13.00

    Methylation profile in diagnostics of soft tissue tumors M. Miettinen

  • 13.00 – 13.45

    Lunch (45′)

  • 13.45 – 14.30

    The new clinical-morphologic entities among soft tissue and bone tumors M. Miettinen

  • 14.30 – 15.15

    Rare colorectal cancer subtypes (NTRK/ ALK/HER2) J. Lasota

  • 15.15 – 15.40

    Coffee (25′)

  • 15.40 – 16.25

    Epigenetics in colon cancer and beyond – from basics to clinicsR. Schneider-Stock

  • 16.25 – 17.10

    IHC neuroendocrine tumours of GI tract and beyondA. Bellizzi

  • 17.10 – 17.55

    Multiplex IHC and multiplex immunofluorescence H-U. Schildhaus

  • 17.55 – 18.00

    Krakow Jewish Quarter – comprehensive guide to the evening walkSpeaker from Jagiellonian Office

  • 20.00 – 22.00

    An evening walk around the Old Town K. Rozwadowska

  • 08.30 – 09.15

    Immunohistochemistry and Molecular Testing in Gynecologic Pathology, What You Need to KnowA. Malpica

  • 09.15 – 10.00

    The role of immunohistochemisty and HPV testing in diagnosing cervical tumors and precursorsS. Stolnicu

  • 10.00 – 10.55

    Immunohistochemical and molecular approaches to the CNS tumor classification (WHO, 2021) W. Grajkowska, J. Trubicka

  • 10.55 – 11.20

    Coffee (25′)

  • 11.20 – 12.15

    IHC approach to unknown primary tumor A. Bellizzi

  • 12.15 – 13.00

    Immunohistochemical and molecular approaches to the hematolymphoid tumors classification (WHO/ICC). Part 1A. Porwit

  • 13.00 – 14.00

    Lunch (60′)

  • 14.00 – 14.45

    Immunohistochemical and molecular approaches to the hematolymphoid tumors classification (WHO/ICC). Part 2 A. Porwit

  • 14.45 – 15.15

    Seminar cases (2 cases) Faculty

  • 15.15 – 15.45

    Digital Pathology in Clinical Practice and ResearchK. Korski

  • 15.45 – 16.15

    Seminar cases (2 cases) Faculty

  • 16.15 – 16.20

    Closing remarks J. Ryś / J. Klos